Raya Therapeutic announces early-stage R&D collaboration with argenx
MONTREAL, July 12, 2023 /PRNewswire/ — Raya Therapeutic Inc., (“Raya”) a mission-driven company focused on the treatment of neurodegenerative diseases,
Read MoreMONTREAL, July 12, 2023 /PRNewswire/ — Raya Therapeutic Inc., (“Raya”) a mission-driven company focused on the treatment of neurodegenerative diseases,
Read MoreVisa and BMO join Barclays and Aviva as Investors in FIL NEW YORK, April 27, 2023 /PRNewswire/ — Anthemis, a
Read MoreIt is the first blood test able to detect early-stage Prostate Cancer with high accuracy in men aged 55 years
Read MoreIt is the first Circulating Tumor Cell detection blood test which is able to identify early-stage Prostate Cancer with high
Read More– RxPONDER, an independent study led by SWOG Cancer Research Network, demonstrates that guiding treatment with Oncotype DX test can
Read More